Study of Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of REGN3500 in Adults With Moderate Asthma

Conditions:   Asthma;   Moderate Asthma
Interventions:   Drug: REGN3500;   Drug: Placebo
Sponsors:   Regeneron Pharmaceuticals;   Sanofi
Not yet recruiting – verified December 2016

View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *